Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems

Japanese Journal of Physiology

Volumn 48, Issue 5, 1998, Pages 301-331

  Arimura, Akira ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Endocrine glands; Nervous system; PACAP; Receptors; Signal transduction

Indexed keywords

ADRENALIN; ARGIPRESSIN; CALCIUM ION; GLUCAGON; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOTHALAMUS HORMONE; INSULIN; INTERLEUKIN 6; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASODILATOR AGENT;

ADRENALIN RELEASE; ALTERNATIVE RNA SPLICING; BRAIN DEVELOPMENT; CELL GROWTH; GENE EXPRESSION REGULATION; HUMAN; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RELEASE; NERVOUS SYSTEM; NEUROENDOCRINE SYSTEM; NEUROPROTECTION; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS;

EID: 0031678491     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.48.301     Document Type: Review

References (240)

1. McCann SM, Mizunuma H, and Samson WK Differential hypothalamic control of FSH secretion: a review. Psychoneuroendocrinology 8: 299-308, 1983
2. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, and Fujino M: A prolactin-releasing peptide in thé brain. Nature 393 272-278, 1998
3. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L Culler MD, and Coy DH: Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164 567-574, 1989
4. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, and Arimura A Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170 643-648, 1990
5. Arimura A, Somogyvan VA, Well C, Fiore RC, Tatsuno I, Bay V, and Brenneman DE: PACAP functions as a neurotrophic factor. Ann NY Acad of Sci 739: 228- 243, 1994
6. Kimura C, Ohkubo S, Ogi K, Hosoya M, Itoh Y, Onda H, Miyata A, Jian L, Dahl RR, Stibbs HH, Arimura A, and Fujino M A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun 166: 81-89, 1990
7. Ogi K, Kimura C, Onda H, Arimura A, and Fujino M: Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP) Biochem Biophys Res Commun 173: 1271-1279, 1990
8. Okazaki K, Itoh Y, Ogi K, Ohkubo S, and Onda H Characterization of murine PACAP mRNA Peptides 16: 1295-1299, 1995
9. Reichlin S. Neuroendocrinology In Williams Textbook of Endocrinology, ed Wilson JD, Foster, DW, Kronnenberg HM, and Larsen PR, WB Saunders Co, Philadelphia, 9th Ed, pp 165-248, 1998
10. Chartrel N, Tonon MC, Vaudry H, and Conlon JM Primary structure of frog pituitary adenylate cyclase activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary Endocrinology 129: 3367- 3371, 1991
11. Yasuhara T, Mizuno K, Somogyvan-Vigh A, Komaki G, and Arimura A Isolation and primary structure of chicken PACAP. Reg Peptides 37: 326, 1992
12. McRory JE, Parker RL, and Sherwood NM: Expression and alternative processing of a chicken gene encoding both growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide. DNA Cell Biol 16: 95-102, 1997
13. McRory JE, Parker DB, Ngamvongchon S, and Sherwood NM Sequence and expression of cDNA for pituitary adenylate cyclase activating polypeptide (PACAP) and growth hormone-releasing hormone (GHRH)-like peptide in catfish Mol Cell Endocrinol 108: 169-177, 1995
14. Parker DB, Coe IR, Dixon GH, and Sherwood NM. Two salmon neuropeptides encoded by one brain cDNA are structurally related to members of the glucagon superfamily. Eur J Biochem 215: 439-448, 1993
15. Matsuda K, Takei Y, Katoh J, Shioda S, Arimura A, and Uchiyama M: Isolation and structural characterization of pituitay adenylate cyclase activating polypeptide (PACAP)-like peptide from the brain of a teleost, Stargazer, uranoscopus japonieus. Peptides 18: 723-727, 1997
16. McRory J and Sherwood NM: Two protochordate genes encode pituitary adenylate cyclase-activating polypeptide and related family members. Endocrinology 138: 2380-2390, 1997
17. Parker DB, Power ME, Swanson P, Rivier J, and Sherwood NM: Exon skipping in the gene encoding pituitary adenylate cyclase-activating polypeptide in salmon alters the expression of two hormones that stimulate growth hormone release Endocrinology 138: 414-423, 1997
18. Hosoya M, Kimura C, Ogi K, Ohkubo S, Miyamoto Y, Shimizu M, Onda H, Oshimura M, Arimura A, and Fujino M: Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochem Biophys Acta 1129: 199-206, 1992
19. Johnson G and Bachman R: A 46,XY,del(18)(pter- p1100.) cebocephalic child from a 46,XX,t(12;18)- (18pter-18p1100::12qter-12pter) normal parent. Hum Genet 34: 103-106, 1976
20. Smeekins SP: Processing of protein precursors by a novel family of subtilisin-related mammalian endoproteases. Biotechnology 11: 182-186, 1993
21. Kew D, Muffy KE, and Kilpatrick DL: Proenkephalin products are stored in the sperm acrosome and may function in fertilization. Proc Natl Acad Sci USA 87 9143-9147, 1990
22. Hilderbrandt JD, Codina J, Tash JS, Kirchick HJ, Lipschultz L, Sekura RD, and Birnbaumer L: The membrane-bound spermatozoal adenylyl cyclase system does not share coupling characteristics with somatic cell adenylyl cyclases Endocrinology 116: 1357- 1366, 1985
23. Neer EJ: Physical and functional properties of adenylate cyclase from mature rat testis. J Biol Chem 249: 6527-6531, 1974
24. Mbikay M, Tadros H, Ishida N, Lerner CP, Lamirande ED, Chen A, El-Alfy M, Clermont Y, Seidah NG, Chretien M, Gagnon C, and Simpson EM: Impaired fertility in mice deficient for the testicular germ-cell protease PC4 Proc Natl Acad Sci USA 94: 6842-6846, 1997
25. Seidah NG, Day R, Hamelin J, Gaspar A, Collard MW, and Chretien M: Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific kex2/subilisin-like proprotein convertase. Mol Endocrinol 6: 1559-1570, 1992
26. Ayer-LeLivere C, Olson L, Ebendal T, Hallbook F, and Persson H. Nerve growth factor mRNA and protein in the testis and epididymis of mouse and rat. Proc Natl Acad Sci USA 85: 2628-2632, 1988
27. Dong W, Seidel B, Marcinkiewicz M, Chretien M, Seidah NG, and Day R: Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei, selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci 17: 563-575, 1997
28. Koves K, Arimura A, Somogyvari-Vigh A, Vigh S, and Miller J: Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase activating polypeptide, in the ovine hypothalamus. Endocrinology 127: 264-271, 1990
29. Li M, Shuto Y. Somogyvan-Vigh A, and Arimura A: Endogenous PC2 and PC1 expressed in neuroendocrine cells process proPACAP. Neuroendocnnology (in press). 1998
30. Shioda S, Legradi G, Leung WC, Nakajo S, Nakaya K, and Arimura A. Localization of pituitary adenylate cyclase-activating polypeptide and its messenger ribonucleic acid in the rat testis by light and electron microscopic immunocytochemistry and in situ hybridization. Endocrinology 135: 818-825, 1994
31. Nakayama K, Kim W-S, Torii S, Hosaka M, Nakagawa T, Ikemizu J, Baba T. and Murakami K: Identification of the fourth member of the mammalian endoproteseaiyhomologous to the yeast kex2 protease. J Biol Chem 1992: 5897-5900, 1992
32. Li M, Nakayama K, Somogivari-Vigh A, and Arimura A Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase activating polypeptide (PACAP) Peptides 17: 259-268, 1998
33. Arimura A and Shioda S: Pituitary adenylate cyclase activating polypeptide (PACAP) and its resceptors: neuroendocrine and endocrine interaction Frontiers Neuroendocrinol 16: 53-88, 1995
34. Arimura A: Receptors for pituitary adenylate cyclase activating polypeptide comparison with vasoactive intestinal peptide receptors. Trends Endocrinol Metab 3: 288-294, 1993
35. Rawlings SR and Hezareh M: Pituitary adenylate cyclase-activatmg polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland Endocrine Rev 17: 4-29, 1996
36. Shivers BD, Gorcs TJ, Gottschall PE, and Arimura A: Two high-affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions. Endocrinology 128: 3055-3065, 1991
37. Gottschall PE, Tatsuno I, Miyata A, and Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase activating polypeptide. Endocrinology 127: 272-277, 1990
38. Cauvin A, Robberecht P, De Neef P, Gourlet P, Vandermeers A, Vandermeers-Piret MC, and Christophe J: Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord Regul Pept 35: 161-173, 1991
39. Robberecht P, Woussen-Colle MC, De Neef P, Bourlet P, Buscail L, Vandermeers A, Vandermeers-Piret MC, and Christophe J: The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP1- 27) and (PACAP1-38) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. FEBS Lett 286: 133-136, 1991
40. Christophe J: Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1154 183-199, 1993
41. Hashimoto H, Ishihara T, Shigernoto R, Mon K, and Nagata S: Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide Neuron 11: 333-342, 1993
42. Hosoya M, Onda H, Ogi K, Masuda Y, Miyamoto Y, Ohtaki T, Okazaki H, Arimura A, and Fujino M Molecular cloning and functional expression of rat cDNA encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 194: 133-143, 1993
43. Morrow JA, Lutz EM, West KM, Fink G, and Harmar AJ Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett 329 99-105, 1993
44. Pisegna JR and Wank SA: Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad of Sci USA 90 6345-6349, 1993
45. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg FH, and Journot L: Differential signal transduction by five splice variants of the PACAP receptor Nature 365: 170-175, 1993
46. Svoboda M, Tastenoy M, Ciccarelli E, Stievenart M, and Christophe J: Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor Biochem Biophys Hes Commun 195: 881-888, 1993
47. Shen Z, Larsson LT, Malmfors G, Absood A, Hakanson R, and Sundler F: A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprong's disease Cell Tissue Res 269: 369- 374, 1992
48. Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, and Fujino M Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor. Biochem Biophys Res Commun 196: 1511-1521, 1993
49. Miyamoto Y, Habata Y, Ohtaki T, Masuda Y, Ogi K, Onda H, and Fujino M: Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP). Biochim Biophys Acta 1218 297-307, 1994
50. Ishihara T, Shigemoto R, Mori K, Takahashi K, and Nagata S: Functional expression and tissue distribution of a novel receptor for vasoactive instestinal polypeptide Neuron 8 811-819, 1992
51. Triguero D, Buclak J, and Pardridge WM: Capillary depletion method for quantification of blood brain barrier transport of circulating peptides and plasma proteins. J Neurochem 54: 1882-1990, 1990
52. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J, and Seino S: Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Nati Acad Sci USA 91: 2679-2783, 1994
53. Svoboda M, Tastenoy M, Van Rampelbergh J, Goossens JF, De Neef P, Waelbroeck M, and Robberecht P Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts Biochem Biophys Res Commun 205 1617-1624, 1994
54. Adamou JE, Aiyar N, Van Horn S, and Elshourbagy NA: Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor Biochem Biophys Res Commun 209: 385-392, 1995
55. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, and Waschek JA: Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP). Pharmacol Rev 50: 265-270, 1998
56. Favit A, Scapagnini U, and Canonico PL: Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cells. Neuroendocrinology 61: 377-382, 1995
57. Basille M, Gonzalez BJ, Desrues L, Demas M, Fournier A, and Vaudry H: Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts J Neurochem 65 1318-1324, 1995
58. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, and Journot L: Alternative splicing in the N-termmal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271: 22146- 22151, 1996
59. Chatterjee TK, Sharma RV, and Fisher RA: Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels J Biol Chem 271: 32226-32232, 1996
60. Okamoto T, Murayama Y, Hayashi Y, Inagaki M, Ogata E, and Nishimoto I. Identification of a Gs activator region of the b2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 67: 723-730, 1991
61. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, and Kikuchi M. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 269: 1290-1293, 1994
62. Sreedharan SP, Robichon A, Peterson KE, and Goetzl EJ Cloning and expression of the human vasoactive intestinal peptide receptor. Proc Natl Acad Sci USA 88: 4986-4990, 1991
63. Couvineau A, Rouyer-Fessard C, Darmoul D, Maoret JJ, Carrera I, Ogier-Denis E, and Laburthe M: Human intestinal VIP receptor, cloning and functional expression of two cDNA encoding proteins with different N- terminal domains. Biochem Biophys Res Commun 200: 769-776, 1994
64. Gagnon AW, Aiyar N, and Elshourbagy NA: Molecular cloning and functional characterization of a human liver vasoactive intestinal peptide receptor Cell Signall 6 321-333, 1994
65. Usdin TB, Bonner TI, and Mezey E: Two receptors for vasoactive intestinal polypeptides with similar specificity and complementary distribution. Endocrinology 135: 2662-2580, 1994
66. Ciccarelli E, Vilardaga JP, De Neef P, Di Paolo E, Waelbroeck M, Bollen A, and Robberecht P: Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Reg Peptides 54: 397-407, 1994
67. Steedharan SP, Patel DR, Xia M, Ichikawa S, and Goetzl EJ: Human vasoactive intestinal peptide, receptors expressed by stable transfectants couple to two distinct signaling pathways. Biochem Biophys Res Commun 203: 141-148, 1994
68. Lutz EM, Sheward WJ, West KM, Morrow JA, Fink G, and Harmar AJ. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334 3-8, 1993
69. Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, and Matsumoto K: Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukm-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells Endocrinology 138: 2515-2520, 1997
70. Rawlings SR, Piuz I, Schlegel W, Bockaert J, and Journot L: Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology 136 2088-2098, 1995
71. Lutz EM, Mendelson S, West K, Mitchell R, and Harmar AJ Molecular characterisation of novel receptors for PACAP and VIP. Biochem Soc Trans 23: 83S, 1995
72. Murthy KS, and Makhlouf GM: Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide-dependent activation of membrane-bound NO synthase in smooth muscle mediated by pertussis toxin-sensitive Gi1-2. J Biol Chem 269: 15977-15980, 1994
73. Buscail L, Cambillau C, Seva C, Scemama JL, De NP, Robberect P, Christophe J, Susini C, and Vaysse N- Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide. Gastroenterology 103: 1002-1008, 1992
74. Monsset J, Douziech N, Rydzewska G, Buscail L, and Rivard N: Cell signalling pathway involved in PACAP- induced AR4-2J cell proliferation Cell Signall 7: 195- 205, 1995
75. Zhong YI: Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophilia Nature 375: 588-592, 1995
76. Villalba M, Bockaert J, and Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway J Neurosci 17: 83-90, 1997
77. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, and Kitada C: Tissue distribution of PACAP as determined by RIA. highly abundant in the rat brain and testes. Endocrinology 129: 2787-2789, 1991
78. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, and Bloom SR, Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol 136: 159- 166, 1993
79. Masuo Y, Suzuki N, Matsumoto H, Tokito F, Matsumoto Y, Tsuda M, and Fujino M: Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res 602: 57-63, 1993
80. Klein DC, Moore RY, and Reppert SM (ed). Suprachiasmatic Nucleus: The Mind's Clock, Oxford Univ Press, New York, 1991
81. Hannibal J, Ding JM, Chen D, Fahrenkrug J, Larson PJ, Gillette MU, and Mikkelsen JD: Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci 17 2637-2644, 1997
82. Palkovits M, Somogyvari-Vigh A, and Arimura A Concentrations of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei. Brain Res 699: 116-120, 1995
83. Koves K, Arimura A, Vigh S, Somogyvari-Vigh A, and Miller J: Immunohistochemical localization of PACAP in the ovine digestive system Peptides 14: 449-455, 1993
84. Kivipelto L, Absood A, Arimura A, Sundler F, Hakanson R, and Panula P: The distribution of pituitary adenylate cyclase activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain. J Chem Neuroanat 5 85-94, 1992
85. Koves K, Arimura A, Gorcs TG, and Somogyvari-Vigh A: Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain Neuroendocrinology 54: 159-169, 1991
86. Vigh S, Arimura A, Koves K, Somogyvari-Vigh A, Sitton J, and Fermin CD Immunohistochemical localization of the neuropeptide, pituitary adenylate cyclase activaing polypeptide (PACAP), in human and primate hypothalamus. Peptides 12: 313-318, 1991
87. Yon L, Feuilloley M, Chartrel N, Arimura A, Conlon JM, Fournier A, and Vaudry H. Immunohistochemical distribution and biological activity of pituitary adenylate cyclase activating polypeptide (PAAP) in the central nervous system of the frog Rana ridibunda. J Comp Neurol 324 485-499, 1992
88. Koves K, Gorcs JT, and Arimura A: Colocalization of PACAP, but not to VIP, with oxytocin in the hypothalamic magnocellular neurons of colchicine treated and pituitary stalk sectioned rats. Endocrine J 2: 1169- 1175, 1994
89. Takahashi K, Totsune K, Murakami O, Satoh F, Sone M, Ohneda M, Sasano H, and Mouri T: Pituitary adenylate cyclase activating polypeptide (PACAP)- like immunoreactivity in human hypothalamus: co-localization with arginine vasopressin. Reg Peptides 50: 267-275, 1994
90. Mikkelsen JD, Hannibal J, Larsen PJ, and Fahrenkrug J: Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex Neurosci Lett 171: 121-124, 1994
91. Zhou J-N, Hofman MA, Gooren LJG, and Swaab DF: A sex difference in the human brain and its relation to transsexuality. Nature 378: 68-70, 1995
92. Kozicz T, Vigh S, and Arimura A. Axon terminals containing PACAP and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 767: 109-119, 1997
93. Uddman R, Goadsby PJ, Jansen I, and Edvinsson L: PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow J Cereb Blood Flow Metab 13: 291-297, 1993
94. Kozicz T, Vigh S, and Arimura A: The source of origin of PACAP- and VIP-immunoreactive fibers in the laterodorsal divisin of the bed nucleus of the stria terminalis in the rat. Brain Res (in press) 1998
95. Legradi G, Shioda S, and Arimura A: Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata. Neurosci Lett 176 193-196, 1994
96. Moller K, Zhang YZ, Hakanson R, Luts A, Sjolund B, Uddman R, and Sundler F. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 57: 725-732, 1993
97. Legradi G, Gorcs TJ, and Arimura A: PACAP-like immunoreactivity and binding sites in putative nociceptive pathways of the spinal cord and brain stem. In: Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides, ed. Rosselin G, World Scientific, Singapore, pp 283-292, 1994
98. Legradi G, Gorcs TJ, and Arimura A: Distribution of pituitary adenylate cyclase activating polypeptide and its binding sites in the spinal cord and spinal trigeminal nucleus. 22nd Annu Meeting Soc Neurosci 18: 48.5, 1992 (abstract)
99. Crute D and Perl ER: Electrophysiological actions of somatostatin and PACAP on cultured dorsal root ganglion (DRG) neurons. Soc Neurosci Abstr 19: 1548, 636 11, 1993
100. Tabarin A, Chen D, Hakanson R, and Sundler F: Pituitary adenylate cyclase-activatmg peptide in the adrenal gland of mammals, distribution, characterization and responses to drugs Neuroendocrinology 59: 113-119, 1994
101. Gaytan F, Martinez-Fuentes AJ, Garcia-Navarro F, Vaudry H, and Aguilar E: Pituitary adenylate cyclase- activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res 276 223- 227, 1994
102. Uddman R, Luts A, Arimura A, and Sundler F: Pituitary adenylate cyclase activating peptide (PACAP), a new vasoactive intestinal peptide (VlP)-like peptide in the respiratory tract Cell Tissue Res 265: 197-201, 1991
103. Cardell LO, Uddman R, Luts A, and Sundler F: Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects. Reg Peptgides 36: 379-390, 1991
104. Koves K and Arirnura A: Immunohistochemical demonstration of pituitary adenylate cyclase activating polypeptide in ovine gut. Southern Society for Clinical Inv, 1991
105. Uddman R, Luts A, Absood A, Arimura A, Ekelund M, Desai H, Hakanson R, Hambreaus G, and Sunder F: PACAP, a VIP-like peptide, in neurons of the esophagus. Reg Peptides 36 415-422, 1991
106. Fridolf T, Sundler F, and Ahren B: Pituitary adenylate cyclase activating polypeptide (PACAP). occurrence in rodent pancreas and effects on insulin and glucgon secretion in the mouse. Cell Tissue Res 269: 275-279, 1992
107. Fahrenkrug J, Steenstrup BR, Hannibal J, Alm P, and Ottesen B Role of PACAP in the female reproductive organs. Ann NY Acad Sci 805: 394-409, 1996
108. Buscail L, Gourlet P, Cauvin P, De Neef P, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P, and Christophe J: Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett 262: 77-81, 1990
109. Lam HC, Takahashi K, Ghatei MA, Kanse SM, Polak JM, and Bloom SR: Binding sites of a novel neuropeptide pituitary adenylate cyclase activating polypeptide in the rat brain and lung Eur J Biochem 193: 725- 729, 1990
110. Masuo Y, Ohtaki T, Masuda Y, Nagai Y, Suno M, Tsuda M, and Fujino M Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain. Neurosci Lett 126: 103-106, 1991
111. Masuo Y, Ohtaki T, Masuda Y, Tsuda M, and Fujino M Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections Brain Res 575: 113-123, 1992
112. Hashimoto H, Nogi H, Mori K, Ohishi H, Shigemoto R, Yamamoto K, Matsuda T, Mizuno N, Nagata S, and Baba A. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol 371: 567-577, 1996
113. Shioda S, Shuto Y, Somogyvari-Vigh A, Legradi G, Onda H, Coy dH, Nakajo S, and Arimura A Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res 28: 345-354, 1997
114. Li M, Shioda S, Somogyvari-Vigh A, Onda H, and Arimura A: Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors. Endocrine J 7: 183-190, 1998
115. Shioda S, Shuto Y, Somogyvari-Vigh A, Onda H, and Arimura A: Distribution of pituitary adenylate cyclase- activating polypeptide (PACAP) receptor in the rat brain. Soc Neurosci Abstr 20 516, 1994
116. Legradi G, Shioda S, Takaki A, and Arimura A: Immunohistochemical mapping of pituitary adenylate cyclase-activating polypeptide (PACAP) in the rat brain. Soc Neurosci Abstr 20: 516, 1994
117. 2+ in rat gonadotropes and somatotropes through different intracellular mechanisms. Endocrinology 132: 1447-1452, 1993
118. Rawlings SR: PACAP, PACAP receptors, and intracellular signalling. Mol Cell Endocrinol 101: C5-C9, 1994
119. 2+], in rat gonadotrophs through an inositol trisphosphate-dependent mechanism. J Biol Chem 269: 5680-5686, 1994
120. Canny BJ, Rawlings SR, and Leong DA. Pituitary adenylate cyclase activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatoropes Endocrinology 130: 211-215, 1992
121. Vigh S, Arimura A, Gottschall PE, Kitada C, Somogyvari-Vigh A, and Childs GV: Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands. Peptides 14: 59-65, 1993
122. Robberecht P, Vertongen P, Velkeniers B, de Neef P, Vergani P, Raftopoulos C, Brotchi J, Hooghe-Peters EL, and Christophe J: Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas. J Clin Endocrinol Metab 77: 1235-1239, 1993
123. 2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta. J Neuroendocrinol 8: 367-374, 1996
124. Hezareh M, Journot L, Bepoldm L, Schlegel W, and Rawlings SR: PACAP/VIP receptor subtypes, signal transducers, and effectors in pituitary cells. Ann NY Acad Sci 805: 315-328, 1996
125. Yada T, Vigh S, and Arimura A: Pituitary adenylate cyclase activating polypeptide (PACAP) increases cytosolic-free calcium concentration in folliculo-stellate cells and somatotropes of rat pituitary. Peptides 14: 235-239, 1993
126. Tatsuno I, Somogyvari-Vigh A, Gottschall PE, Mizuno K, Hidaka H, and Arimura A Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by piuitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology 129: 1797-1804, 1991
127. Matsumoto H, Koyama C, Sawada T, Koike K, Hirota K, Miyake A, Arimura A, and Inoue K: Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating pepttde), showing increased adenosine 3′,5′-monophosphate and interleukin-6 secretion and cell proliferation. Endocrinology 133: 2150-2155, 1993
128. Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, and Coiro V: Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal hormone secretion in normal men. Neuroendocrinology 64: 242-246, 1996
129. Culler MD and Paschall CS. Pituitary adenylate cyclase activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone. Endocrinology 129: 2260- 2262, 1991
130. Young LS, Nalk SI, and Clayton RN: Adenosine 3′,5′- monophosphate derivatives increase gonadotropin- releasing hormone receptors in cultured rat pituitary cells Endocrinology 114: 2114-2122, 1984
131. Janovick JA and Conn PM: A cholera toxin-sensitive guanylyl nunleotide binding protein mediates the movement of pituitary luteiningin hormone into a releasable pool: loss of the event is associated with the onset of homologous desensitization to gonadotropin- releasing hormone. Endocrinology 132: 2131-2135, 1993
132. Tsujii T, Ishizaka K, and Winters SJ: Effects of pituitary adenylate cyclase-activatmg polypeptide on gonadotropin secretion and subunit messenger ribonucleic acids in perrfused rat pituitary cells. Endocrinology 135: 826-833, 1994
133. Tsujii T and Winters SJ: Effects of pulsatile pituitary adenylate cyclase activating polypeptide (PACAP) on gonadotropin secretion and subunit mRNA levels in perifused rat pituitary cells. Life Sci 56: 1103-1111, 1995
134. Schomerus E, Poch A. Bunting R, Mason WT, and McArdle CA: Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line. Endocrinology 134: 315- 323, 1994
135. Nagy MG, Vigh S, and Arimura A: PACAP induces prolactin and growth hormone release in lactating rats separated from their pups. Endocrine J 1: 169-173, 1993
136. Jarry H, Leonhardt S, Schmidt WE, Creutzfeldt W, and Wuttke W: Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats Life Sci 51: 823-830, 1992
137. Velkeniers B, Zheng L, Kazemzadeh M, Robberecht P, Vanhaelst L, and Hooghe-Peters EL: Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression. J Endocrinol 143: 1-11, 1994
138. Dow RC, Bennie J, and Fink G: Pituitary adenylate cyclase-activatmg peptide-38 (RACAP-38) is released into hypophysial portal blood in the normal male and female rat. J Endocrinol 142: R1-R4, 1994
139. Coleman DT and Bancroft C. Pituitary adenylate cyclase-activatmg polypeptide stimulates prolactin gene expression in a rat pituitary cell line. Endocrinology 133: 2736-2742, 1993
140. Koch B and Lutz-Bucher B Pituitary adenylate cyclase activating popeptide (PACAP) stimulates cAMP formation as well as peptide output of cultured pituitary melanotrophs and atT20 corticotrophs Reg Peptides 38: 45-53, 1992
141. Propato-Mussafiri R, Kanse SM, Ghatel MA, and Bloom SR: Pituitary adenylate cyclase activating polypeptide released 7B2, adrenocoticotrophin, growth hormone and prolactin from the mouse and rat clonal pituital cell lines AtT-20 and GH3. J Endocrinol 132: 107-113, 1992
142. Braas KM, Brandenburg CA, and May V: Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion. Endocrinology 134 186- 195, 1994
143. Koch B and Lutz-Bucher B: Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor. Cell Signall 6: 467-473, 1994
144. Boutillier AL, Monnier D, Koch B, and Loeffler JP. Pituitary adenyl cyclase-activating peptide: a hypophysiotropic factor that stimulates proopiomelanocortin gene transcription, and proopiomelanocortin-derived peptide secretion in corticotropic cells Neuroendocrinology 60: 493-502, 1994
145. Monnier D, Galddon C, Boutiliier AL, Barthel F, and Loeffer JP: PACAP27 and 38 stimulate proopiomelanocortin (POMC) and peoenkephalm (PENK) gene transcription. Reg Peptides 54 199-200, 1994 (abstract)
146. Boutiller AL, Monnier D, Koch B, Roberts JL, and Loeffler JPH: PACAP and CRH regulate gene transcription by protein kinase A and c-fos dependent
147. Koves K, Molnar J, Kantor O, Gorcs TJ, Lakatos A, and Arimura A: New aspects of the neuroendocrine role of PACAP. Ann NY Acad Sci 805: 648-654, 1996
148. Shioda S, Yada T, Nakajo S, Nakaya K, Nakai Y, and Arimura A: Pituitary adenylate cyclase-activating polypeptide (PACAP): a novel regulator of vasopressin-containing neurons Brain Res 765 81-90, 1997
149. Lutz-Bucher B, Monnier D, and Koch B: Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion Neuroendocrinology 64: 153-161, 1996
150. Chiodera P, Volpi R, Capretti L, and Coiro V: Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man Neuroreport 6: 1490-1492, 1995
151. Kawai K, Ohse C, Watanabe Y, Suzuki S, Yamashita K, and Ohashi S: Pituyitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas. Life Sci 50: 257-261, 1992
152. Yokota C, Kawai K, Ohashi S, Watanabe Y, Suzuki S, and Yamashita K: Stimulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on insulin and glucagon release from the isolated perfused rat pancreas. Acta Endocrinol 129: 473-479, 1993
153. Yada T, Sakurada M, Nakata M, Ihida K, Yaekura K, Shioda S, and Kikuchi M. Current status of PACAP as a regulator of insulin secretion in pancreatic islets Ann NY Acad Sci 805: 329-342, 1996
154. Ashcroft FM and Rorsman P: Electrophysiology of the pancreatic b-cell. Prog Mol Biol 54: 87-143, 1989
155. 2+ signaling pathway in pancreatic b-cells by the insulinotropic hormone glucagon- like peptide-1. J Biol Chem 270: 17749-17757, 1995
156. Leech CA, Holz GG, and Habener JF: Pituitary adenylate cyclase-activating polypeptide induces the voltage-independent activation of inward membrane currents and elevation of intracellular calcium in HIT-T15 insulinoma cells. Endocrinology 136: 1530-1536, 1995
157. Frodin M, Hannibal J, Wulff BS, Gammeltoft S, and Fahrenkrug J: Neuronal localization of pituitary adenylate cyclase activating polypeptide 38 in the adrenal medulla and growth inhibiting effects on chromaffin cells. Neuroscience 65: 599-608, 1995
158. Yon L, Chartrel N, Feuilloley M, De Marchis S, Fournier A, De Rijk E, Pelletier G, Roubos E, and Vaudry H: Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology 135: 2749-2758, 1994
159. Dun NJ, Tang H, Dun SL, Huang R, Dun EC, and Wakade AR: Pituitary adenylate cyclase activating polypeptide-immunoreactive sensory neurons innervate rat adrenal medulla Brain Res 716: 11-21, 1996
160. Chowdhury PS, Guo X, Wakade TD, Przywara DA, and Wakade AR. Exocytosis from a single rat chromaffin cell by cholinergic and peptidergic neurotransmitters Neuroscience 59: 1-5, 1994
161. Guo X and Wakade AR: Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals J Physiol (Lond) 475: 539-545, 1994
162. 2--dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells. Endocrinology 132: 1757-1765, 1993
163. Watanabe T, Masuo Y, Matsumoto H, Suzuki N, Ohtaki T, Masuda Y, Kitada C, Tsuda M, and Fujino M: Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem Biophys Res Commun 182: 403-411, 1992
164. Wakade AR, Guo X, Strong R, Arimura A, and Haycock J: Pituitary adenylate cyclase-activating polypeptide (PACAP) as a neurotransmitter in rat adrenal medulla Reg Peptides 37: 331, 1992
165. Watanabe T, Ohtaki T, Kitada C, Tsuda M, and Fujino M: Adrenal pheochromocytoma PC12h cells respond to pituitary adenylate cyclase activating polypeptide. Biochem Biophys Res Commun 173 252-258, 1990
166. Morita K, Dohi T, Kitayama S, Koyama Y, and Tsujimoto A: Enhancement of stimulation-evoked catecholamine release from cultured bovine adrenal chromaffin cells by forskolin. J Neurochem 48: 243-247, 1987
167. 2- uptake and catecholamine secretion in primary dissociated cultures of adrenal medulla. J Neurochem 39: 635-646, 1982
168. Isobe K, Nomura F, Takekoshi K, and Nakai T: Pertussis toxin pretreatment enhances catecholamine secretion induced by pituitary adenylate cyclase-activating polypeptide in cultured porcine adrenal medullary chromaffin cells, a possible role of the inositol lipid cascade. Neuropeptides 27: 269-275, 1994
169. Wakade AR. Noncholinergic transmitter(s) maintains secretion of catecholamines from rat adrenal medulla for several hours of continuous stimultion of splanchnic neruons J Neurochem 50: 1302-1308, 1988
170. Wakade TD, Blank MA, Malhotra RK, Pourcho R, and Wakade AR: The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion. J Physiol (Lond) 444: 1991
171. Rius RA, Guidotti A, and Costa E: Pituitary adenylate cyclase activating polypeptide (PACAP) potently enhances tyrosine hydroxylase (TH) expression in adrenal chromaffin cells Life Sci 54: 1735-1743, 1994
172. Ames MM, Lerner MP, and Lovenberg W Tyrosine hydroxylase Activation by protein phosphorylation and end product inhibition. J Biol Chem 253: 27-31, 1978
173. Haycock JW: Phosphorylation of tyrosine hydroxylase in situ at serine J Biol Chem 265: 11682-11691, 1990
174. Haycock JW: Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP. Ann NY Acad Sci 805 219-231, 1996
175. Edwards AV and Jones CT. Adrenal responses to the peptide PACAP in conscious functionally hypophysectomized calves. Am J Physiol 266: E870-E876, 1994
176. Andreis PG, Malendowicz LK, Belloni AS, and Nussdorfer GG Effects of pituitary adenylate-cyclase activating peptide (PACAP) on the rat adrenal secretory activity, preliminary in-vitro studies. Life Sci 56: 135- 42, 1995
177. Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, and Nussdorfer GG: Pituitary adenylatecyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab 81: 169- 173, 1996
178. Bodart V, Babinski K, Ong H. and De Lean A: Comparative effect of pituitary adenylate cyclase-activatmg polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells. Endocrinology 138: 566-573, 1997
179. Hannibal J and Fahrenkrug J: Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells. Reg Peptides 55: 111-115, 1995
180. Kononen J, Paavola M, Penttila TL, Parvinen M, and Pelto HM: Stage-specific expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in the rat seminiferous tubules. Endocrinology 135: 2291-2294, 1994
181. Daniel PB and Habener JF: Expression of PACAP in seminiferous tubules: a highly stage specific cAMP trigger Abstracts, 79th Annual Meeting of Endocrine Society P3-382 (532), 1997
182. Shuto Y, Somogyvari-Vigh A, Shioda S, Onda H, and Arimura A: Effect of hypophysectomy on pituitary adenylate cyclase-activating polypeptide gene expression in the rat testis. Peptides 16 1039-1044, 1995
183. Shivers BD, Gorcs TJ, Coy DH, Arimura A, and Gottschall PE: VIP antagonist inhibits PACAP signal transduction at type II but not type I receptors Prog Annu Meeting Soc Neurosci Abstract, 1991
184. Heindel JJ, Powell CJ, Paschall GS, Arimura A, and Culler MD A novel hypothalamic peptide, pituitry adenylate cyclase activating peptide, modulates Sertoli cell function in vitro. Biol Reprod 47: 800-806, 1992
185. West AP, McKinnell C, Sharpe RM, and Saunders PTK: Pituitary adenylate cyclase activating polypeptide can regulate testicular germ cell protein synthesis in vitro J Endocrinol 144 215-223, 1995
186. Pesce M, Canipari R, Ferri GL, Siracusa G, and De Felici M: Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylate cyclase and promotes proliferation of mouse primordial germ cells Development 122: 215-221, 1996
187. Rossato M, Nogara A, Gottardello F, Bordon P, and Foresta C: Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway. Endocrinology 138: 3228-3235, 1997
188. Shioda S, Nakai Y, Nakajo S, Nakaya K, and Arimura A: Loacalization of pituitary adenylate cyclase activating polypeptide and its type I receptors in the rat ovary: immunohistochemistry and in situ hybridization Ann NY Acad Sci 805: 677-683, 1996
189. Scaldaferri L, Arora K, Lee SH, Catt KJ, and Moretti C: Expression of PACAP and its type-I receptor isoforms in the rat ovary. Mol Cell Endocrinol 117: 227-232, 1996
190. Gras S, Hannibal J, Georg B, and Fahrenkrug J: Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells Endocrinology 137: 4779-4785, 1996
191. Gobbetti A, Zerani M, Miano A, Bramucci M, Murri O, and Amici D: Presence of pituitary adenylate cyclase- activating polypeptide 38-immuno-like material in the brain and ovary of the female crested newt, Triturus carnifex: its involvement in the ovarian synthesis of prostaglandins and steroids. J Endocrinol 152: 141-146, 1997
192. Kotani E, Usuki S, and Kubo T: Effect of pituitary adenylate cyclase-activating polypeptide 9PACAPO on progestin biosysnthesis in cultured granulosa cells from rat ovary and expression of mRNA encoding PACAP type IA receptor. J Reprod Fertil 112: 107-114, 1998
193. Zhong Y, and Kasson BG Pituitary adenytate cyclaseactivating polypeptide stimulates steroidogenesis and adenosine 3′,5′-monophosphate accumulation in cultured rat granulosa cells. Endocrinology 135: 207- 213, 1994
194. Chung S-Y, Lee J, Park H-J, Choi H-S, Kwon H-B, and Arimura A: Gonadotropin regulation of pituitary adenylate cyclase activating plypeptide mRNA in the rat ovary Program of the 80th Annual Meeting Endocrine Society 89, 1998
195. Koves K, Vigh S, Somogyvari-Vigh A, and Arimura A: Pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactive neuronal systems in the rat, sheep and primate brain. Annu Meeting Eur Neuroendocrinol Assoc Abstr, 1991
196. Zhang YZ, Sjolund B, Moller K, Hakanson R, and Sundler F: Pituitary adenylate cyclase activating peptide produces a marked and long-lasting depression of a C-fibre-evoked flexion reflex. Neuroscience 57: 733-737, 1993
197. Yamamoto T and Tatsuno I Antmociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test. Neurosci Lett 184: 331-334, 1995
198. Warren JB, Larkin SW, Coughlan M, Kajekar R, and Williams TJ: Pituitary adenylate cyclase activating- polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo. Br J Pharmacol 106: 331-334, 1992
199. Masuo Y, Matsumoto Y, Tokito F, Tsuda M, and Fujino M: Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis Brain Res 611: 207-215, 1993
200. Huang Q, Legradi G, and Arimura A Perfusion of the paraventricular nucleus with pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide stimulates local release of norepinephrine and its metabolite: microdialysis study in freely moving rats. Ann NY Acad Sci 805: 737-742, 1996
201. Anderson CR, Edwards SL, Furness JB, Bredt DS, and Snyder SH: The distribtion of nitric oxide synthase-contaming autonomic preganglionic terminals in the rat. Brain Res 614: 78-85, 1993
202. Sundler F, Ekblad E, Hannibal J, Moller K, Shang YZ, Mulder H, Elsas T, Grunditz T, Danielsen N, Fahrenkrug J, and Uddman R Pituitary adenyate cyclase activating peptide in sensory and autonomic ganglia, localization and regulation. Ann NY Acad Sci 805 410-426, 1996
203. Tobin G, Asztely A, Edwards AV, Ekstrom J, Hakanson R, and Sundler F Presence and effects of pituitary adenylate cyclase activating peptide in the submandibular gland of the ferret Neuroscience 66 227- 235, 1995
204. Stella N and Magistretti PJ. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamateevoked release of arachidonic acid from mouse cortical neurons Evidence for a cAMP-independent mechanism J Biol Chem 271: 23705-23710, 1996
205. Martin JL, Gasser D, and Magistretti PJ: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons. J Neurochem 65: 1-9, 1995
206. Magistretti PJ and Martin JL: VIP and PACAP in the CNS modulators of synaptic transmission and mediators of neuron glia communication. Reg Peptide 71: 121, 1997 (abstract)
207. May V, Beaudet MM, Hardwick JC, Parsons RL, Harakall SA, Gauthier E, Durda JP, and Brass KM. Pituitary adenylate cyclase activating polypeptides depolarise and increase the excitablity of sympathetic neurons through activation of tyep I PACAP-selective receptors. Reg Peptide 71: 122, 1997 (abstract)
208. Tatsuno I, Yada T, Vigh S, Hidaka H, and Arimura A Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosotic free calcium concentration in cultured rat hippocampal neurons. Endocrinology 131 73-81, 1992
209. Przywara DA, Guo X, Angelilli ML, Wakade TD, and Wakade AR: A non-cholinergic transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells J Biol Chem 271: 10545- 10550, 1996
210. Crespo P, Xu N, Simonds WF, and Gulkind JS: Rasdependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369: 418-420, 1994
211. van Corven EJ, Hordijk PL, Medema RH, and Bos JL: Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 90: 1257-1261, 1993
212. Egan SE and Weinberg RA: The pathway to signal achievement. Nature 365: 781-783, 1993
213. Horvitz HR and Sternberg PW: Multiple intercellular signalling systems control the development of the caenorhabditis elegans vulva. Nature 351: 535-541, 1991
214. Zhong Y: Genetic dissection of signal transduction mechanisms underlying PACAP-like neuropeptide transmission in Drosophila synergy of cAMP and Ras/Raf pathways. Ann NY Acad Sci 805: 67-80, 1996
215. Deutsch PJ, Schadlow V, and Barzilai N: 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells. J Neurosci Res 35: 312-320, 1992
216. Deutsch PJ and Sun Y. The 38 amino acid form of pituitary adenylate cyclase activating polypeptide stimulates dual signalling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 267: 5108- 5113, 1992
217. DiCicco-Bloom E and Deutsch PJ. Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis. Neuritogenesis and survival in cultured rat sympathetic neuronblasts Reg Peptides 37: 319. 1992 (abstract)
218. Weill CL, Treuil M, and Arimura A. The neurotrophic actions of PACAP27 on PC 12 cells. Abstr, Soc Neurosci 18: 1475, 1992
219. Hamburger V and Levi-Montalcini R Proliferation, differentation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111: 457-502, 1949
220. Wakade AR: Sympathetic neurons of chic embryo are rescued by PACAP from apoptotic death. Reg Peptides 71: 141, 1997 (abstract)
221. Canonico PL, Copani A, D'Gata V, Musco S, Petralia S, Travail S, Stivala F, and Cavallaro S: Activation of pituitary adenylate cyclase activating polypeptide receptors prevents apoptotic cell death in cultured cerebellar granule cells Ann NY Acad Sci 805: 470- 472, 1996
222. Morio H, Tatsuno I, Tanaka T, Uchida D, Hirai A, Tamura Y, and Saito Y: Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neurotrophic factor for cultured rat cortical neurons. Ann NY Acad Sci 805: 476-481, 1996
223. Brenneman DE, Fitzgerald S, and Litzinger MJ: Neuronal survival during electorical blockade is increased by 8-bromo cyclic adenosine 3′,5′-monophosphate. J Pharmacol Exp Ther 233: 402-408, 1985
224. Rydell R and Greene LA: cAMP analogs promote the survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA 85: 1257- 1261, 1988
225. Kaiser PK and Lipton SA: VIP-mediated increase in cAMP prevents tetrodotoxm-induced retinal ganglion cell death in vitro. Neuron 5: 558-570, 1990
226. --induced degeneration. J Neurosci Res 32: 190-201, 1992
227. Sklair-Tavron L and Segal M: Neurotrophic effects of cAMP generating systems on central noradrenergic neurons Brain Res 614: 257-269, 1993
228. Gonzalez BJ, Basille M, Vaudry D, Fournier A, and Vaudry H: Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neunte outgrowth in rat cerebellar neuroblasts Neuroscience 78: 419-430, 1997
229. Campard PK, Crochemore C, Rene F, Monnier D, Koch B, and Loeffler JP. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway DNA Cell Biol 16 323-333, 1997
230. Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, and Vaudry H: Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells. Neuroscience 57: 329-338, 1993
231. Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, and Vaudry H: Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84: 801-812, 1998
232. Lioudyno M, Skoglosa Y, Takei N, and Lindholm D: Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-releated peptide (CGRP) immunoreactivity in vitro. J Neurosci Res 51: 243-256, 1998
233. Brenneman DE, Westbrook GL, Fitzgeral SP, Ennist DL, Elkins KL, Ruff MR, and Pett CB: Neuronal cell killing by the envelop protein of HIV and its prevention by vasoactive intestinal pepide. Nature 335: 639-642, 1988
234. Lu N and DiCicco-Bloom E: Pituitary adenylate cyclase-activatmg polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci USA 94: 3357-3362, 1997
235. Brenneman DE, Neale EA, Foster GA, d'Autremont SW, and Westbrook GL: Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J Cell Biol 104: 1603-1610, 1987
236. Pulsinelli WA and Brierly JB A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10: 267-272, 1979
237. Pulsinelli WA and Buchnan AM: The utility of animal ischemia models in predicting pharmacotherapeutic response in the clinical setting In Cerebrovascular Diseases, ed. Ginsberg MD and Dietrich WD, Raven Press, New York, pp 87-91, 1989
238. Uchida A, Arimura A, Somogyvari-Vigh A, Shioda S, and Banks WA: Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 736: 280-286, 1996
239. Banks WA, Kastin AJ, Komaki G, and Arimura A: Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267 690-696, 1993
240. Paxinos G and Watson T: Rat Brain in Sterotaxic Coordinates, Academic Press, New York, 1982